University of Nevada, Reno computer science engineering team Kostas Bekris and Eelke Folmer presented their indoor navigation system for people with visual impairments at two national conferences recently…
Author: Medical News Today
Smartphones A Big Help To Visually Impaired
iPhones and other smartphones can be a huge help to the visually impaired, but few vision doctors are recommending them to patients, according to a study co-authored by a Loyola University Chicago Stritch School of Medicine ophthalmologist. Researchers…
Eye Cancer Tumors Likely To Spread Can Be Identified By Genetic Test
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver…
Vision Loss Due To Degenerative Eye Diseases May Be Restored By New Type Of Retinal Prosthesis
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenera…
A Killer Of Superbugs
Better than antibiotics, it is being used in contact lenses to prevent infections and biomedical products are the next stage The superbugs have met their match. Conceived at Nanyang Technological University (NTU), it comes in the form of a coating whic…
Topical Aganirsen Found To Be Active In Retinal Disease
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced that positive data from a study of aganirsen (GS-101, eye drops) in a nonhuman primate model of choroidal neovascularization has been p…
New Advances In Treating Inherited Retinal Diseases
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in …
Metformin For Diabetes May Treat Uveitis, A Leading Cause Of Blindness
University of Texas Medical Branch at Galveston researchers have discovered that a drug already prescribed to millions of people with diabetes could also have another important use: treating one of the world’s leading causes of blindness…
Genetic Predictor For Fuchs’ Corneal Dystrophy Confirmed By Mayo Clinic
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual’s risk of developing the eye condition Fuchs’ dystrophy. The findings were presented at the an…
Wet Age-Related Macular Degeneration Responds Equally To Avastin And Lucentis
The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported at an international research meeting in Fort …
Study Proposals Could Reduce Diabetic Retinopathy Screening Costs By Around 25 Percent
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopath…
Problems In Transport Of Donated Human Retina Led Researchers To Discover New Treatment Path For Eye Disease
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge revi…
Transplanting Whole Cornea Not Always Necessary
Worldwide, corneas are the most frequently transplanted tissue. However, because of rapid advances, the long-developed technique of complete transplantation, i.e. penetrating keratorplasty (PK) is no longer necessary in many instances…
Age-Related Macular Degeneration – How To Tackle Increasing Rates
With aging populations, age-related macular degeneration (AMD) is set to increase. AMD, which causes progressive blindness, may already be present in the early stages in 20% of 60 year-olds and those who are older in some countries…
First Oral Agent To Quell Invasive Macular Degeneration, Restore Lost Vision
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered…
Myopia, Short-sightedness Rates Very High In East Asia
Around 80% to 90% of school-leavers in major East Asian cities like China, Taiwan, Hong Kong, Japan, Singapore and South Korea suffer from myopia or short-sightedness…
Interpreting The Avastin-Lucentis Study For Persons With Macular Degeneration
This week, the second-year results of an important clinical trial on age-related macular degeneration (AMD), known as the Comparison of AMD Treatments Trials (or CATT), were published in the journal Ophthalmology. Researchers found that two drugs known…
Comparison Of Avastin And Lucentis In Treating Age-Related Macular Degeneration
At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision …
Major Breakthrough In Macular Degeneration Research
University of Kentucky researchers, led by Dr. Jayakrishna Ambati, have made a major breakthrough in the “dry” form of age-related macular degeneration known as geographic atrophy (GA). GA is an untreatable condition that causes blindness in millions o…
Transplantation Of Fetal Membrane To Prevent Blindness
Transplanting tissue from newborn fetal membranes prevents blindness in patients with a devastating disease called Stevens-Johnson syndrome, a Loyola University Medical Center study has found. The study by senior author Charles Bouchard, MD, and collea…